Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
35.12
+2.18 (6.62%)
At close: Feb 6, 2026, 4:00 PM EST
35.00
-0.12 (-0.34%)
After-hours: Feb 6, 2026, 6:23 PM EST
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $2.73 billion as of February 6, 2026. Its market cap has increased by 142.94% in one year.
Market Cap
2.73B
Enterprise Value
2.24B
1-Year Change
142.94%
Ranking
Category
Stock Price
$35.12
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $2.73B, an increase of 2,339.60%. That is a compound annual growth rate of 38.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 2.73B | 7.20% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 3.01B |
| Catalyst Pharmaceuticals | 3.00B |
| Apellis Pharmaceuticals | 2.97B |
| IDEAYA Biosciences | 2.82B |
| Viridian Therapeutics | 2.79B |
| Dyne Therapeutics | 2.77B |
| Immunome | 2.75B |
| Tarsus Pharmaceuticals | 2.74B |